ALK-driven NSCLC: A narrative review - Part I

Anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) is a molecularly distinct subgroup of oncogene-addicted NSCLC, accounting for 3-5% of cases. These are mainly genomic rearrangements resulting in a fusion oncoprotein, thus causing persistent constitutive signaling. Recen...

Full description

Bibliographic Details
Main Authors: Shrinidhi Nathany, Mansi Sharma, Ullas Batra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=2;spage=272;epage=278;aulast=Nathany